CDC - Upcoming COCA Call: August 9 ? Updated Interim Zika Clinical Guidance for Pregnant Women and Data on Contraceptive Use to Decrease Zika-affected

[sharon sanders]

From: "=?US-ASCII?Q?Centers_for_Disease_Control_and_Preve...
To: flutrackers@earthlink.net
Subject: Upcoming COCA Call: August 9 ? Updated Interim Zika Clinical Guidance for Pregnant Women and Data on Contraceptive Use to Decrease Zika-affected Pregnancies
Date: Aug 4, 2016 1:16 PM

[TABLE="class: msgbody, border: 0, cellpadding: 0, cellspacing: 0"]
[TR]
[TD] [TABLE="class: gd_tbl_wrap, align: center, border: 0, cellpadding: 0, cellspacing: 0"]
[TR]
[TD] [TABLE="align: center, border: 0, cellpadding: 0, cellspacing: 0"]
[TR]
[TD][/TD]
[/TR]
[TR]
[TD] [h=1]Updated Interim Zika Clinical Guidance for Pregnant Women and Data on Contraceptive Use to Decrease Zika-affected Pregnancies[/h] [/TD]
[/TR]
[TR]
[TD] [TABLE="border: 0, cellpadding: 0, cellspacing: 0"]
[TR]
[TD="width: 50%"]

​

[h=2]Overview:[/h]

CDC?s top priority for the Zika response is to protect pregnant women and their fetuses from the adverse effects of Zika virus infection in pregnancy. As a result, CDC continues to evaluate all available evidence and update recommendations as new information becomes available. CDC has updated its interim guidance for U.S. healthcare providers caring for pregnant women with possible Zika virus exposure based on emerging evidence about laboratory testing for the diagnosis of Zika. A primary strategy to reduce Zika-related pregnancy complications is to prevent pregnancy among women who want to delay or avoid pregnancy. CDC published contraceptive use data for states where mosquito-borne transmission of Zika is possible.​

During this COCA Call, clinicians will learn about the updated CDC interim guidance for caring for pregnant women with possible Zika virus exposure, and strategies for increasing access to contraceptive methods and services to minimize the number of pregnancies affected by Zika.​

[h=2]Objectives[/h]

? Discuss revised diagnostic testing for Zika virus infection among pregnant women.​

? Discuss clinical management of pregnant women with confirmed or possible Zika virus infection.​

? Review use of a range of contraceptive methods in states, with a focus on highly effective methods.​

? Define strategies for increasing access and availability to highly effective contraception.​

[/TD]
[TD="width: 50%"]

Date: Tuesday, August 9, 2016​

Time: 2 :00 - 3:00 pm (Eastern Time)​

Join by Phone:
888-942-9686 (U.S. Callers)
517-308-9076 (International Callers)​

​

Join by Webinar​

The recordings (audio, slides, and transcript) for this call will be posted on the webpage a few days after the COCA Call.​

​

​

Follow these steps to earn free continuing education.​

​

​

​

​

​

​

​

[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD] [h=2]Presenters:[/h]

​

Charlan D. Kroelinger, PhD, MA
Team Lead
Division of Reproductive Health
National Center for Chronic Disease Prevention and Health Promotion
Centers for Disease Control and Prevention​

Erin Berry-Bibee, MD, MPH
Guest Researcher / Assistant Professor
Division of Reproductive Health
Centers for Disease Control and Prevention
Department of Obstetrics and Gynecology
University of North Carolina Chapel Hill​

Titilope Oduyebo, MD, MPH
Medical Officer
Division of Reproductive Health
National Center for Chronic Disease Prevention and Health Promotion
Centers for Disease Control and Prevention​

[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[/TABLE]

 

[sharon sanders]

bumping